ELARESP Trademark

Trademark Overview


On Friday, July 5, 2013, a trademark application was filed for ELARESP with the United States Patent and Trademark Office. The USPTO has given the ELARESP trademark a serial number of 86003281. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 17, 2015. This trademark is owned by Glaxo Group Limited. The ELARESP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
elaresp

General Information


Serial Number86003281
Word MarkELARESP
Filing DateFriday, July 5, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 17, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ELARESP" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 16, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, August 17, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 17, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 24, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 23, 2015EXTENSION 2 GRANTED
Tuesday, December 2, 2014EXTENSION 2 FILED
Thursday, January 22, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Wednesday, June 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 23, 2014EXTENSION 1 GRANTED
Monday, June 23, 2014EXTENSION 1 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Tuesday, January 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 9, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2013ASSIGNED TO EXAMINER
Tuesday, July 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 9, 2013NEW APPLICATION ENTERED IN TRAM